As far as Simvastatin is concerned, it seems like 80mg of this statin is way too much of a good thing. In a June 2011 notice, The Food and Drug Administration recommended that the use of drugs containing 80 mg of simvastatin—the highest approved dose of the popular cholesterol-lowering stat …Read More
A promising new study found that Coenzyme Q10 may slow the progression of Parkinson's disease. This is potentially an incredible breakthrough because although existing treatments may ease symptoms of the degenerative brain disorder, they are not believed to affect the underlying disease process. This new study found …Read More
In a major breakthrough study Danish researchers determined that Coenzyme Q10 cuts mortality by half in patients with heart failure. Professer Svend Age Mortensen explained that it’s been ten years since a medication / supplement has shown to improve heart failure mortalit …Read More
We recently received an email from a customer that led us to ask; Is Mitochondrial Impairment the cause of many of the symptom …Read More
Q-Gel® CoQ10 passes the dissolution test and provides optimum relative bioavailability as evidenced in human, animal and in-vitro studies. We have the proof in the clinical trials. There are a number of clever ways that advertisers of many other types of CoQ10 market their product to get you to believe that …Read More
The following information is from a U.S. Government web site (the National Cancer Institute at the National Center for Complementary and Alternative Medicine
What is the history of the discovery and use of coenzyme Q10 as a complementary or alternative treatment for cancer?
Coenzyme Q10 …Read More
The effects of oral treatment with coenzyme Q10 (120 mg per day) were compared for 28 days in a randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction.
The trial consisted of a total of 144 patients with acute myocardial infarction (AMI). 73 of the 144 patients were p …Read More
The global coenzyme Q10 (CoQ10) market is expected to reach USD 1.36 billion by 2024, according to a new report by Grand View Research, Inc. Increasing use in cosmetic formulations is a key driving factor for industry growth.
Asia Pacific is poised to be the fastest growing regional market …Read More
Systemic hypertension, (high blood pressure), affects more than 60 million adults in the United States. Worldwide, it is one of the most common risk factors for cardiovascular morbidity and mortality.
A randomized, double-blind, placebo-controlled clinical trial of Coenzyme Q10 in Isolated Systolic Hypertension was recently …Read More
In the November 2003 issue of Good Housekeeping, (page 83), leading heart surgeon Mehmet Oz, (Professor of Surgery at Columbia University College of Physicians & Surgeons and Attending Surgeon at Columbia Presbyterian Division of Cardiothoracic Surgery …Read More